Key result
Plasma ANGPT2 levels > 833 pg/ml were independently associated with Stanford type A acute aortic dissection (RR 47.297) and showed high diagnostic accuracy with an AUC of 0.93.
Why the study?
Biomarker-assisted diagnosis of acute aortic dissection is important for prompt treatment and survival, but identifying blood biomarkers remains challenging.
Does plasma ANGPT2 level accurately diagnose acute aortic dissection compared to healthy controls?
Case-Control (n=159)
No
Does plasma ANGPT2 level accurately diagnose acute aortic dissection compared to healthy controls?
Relative Risk: 47.297 (95% CI 16.497–135.601)
p-value: p=<0.001
Plasma ANGPT2 is significantly elevated in acute aortic dissection and demonstrates high diagnostic accuracy, suggesting its potential as a novel biomarker.
May support ANGPT2 testing in suspected acute aortic dissection; leaves open prospective validation before clinical adoption.
Biomarker-assisted diagnosis of acute aortic dissection (AAD) is important for initiation of treatment and improved survival. However, identification of biomarkers for AAD in blood is a challenging task. The present study aims to find the potential AAD biomarkers using a transcriptomic strategy. Arrays based genome-wide gene expression profiling were performed using ascending aortic tissues which were collected from AAD patients and healthy donors. The differentially expressed genes were validated using quantitative reverse transcriptase PCR (qRT-PCR) and western blot. The plasma levels of a potential biomarker, angiopoietin 2 (ANGPT2) were determined in case-control cohort (77 AAD patients and 82 healthy controls) by enzyme linked immunosorbent assay. Receiver operating characteristic curve (ROC) was used to evaluate the diagnostic power of ANGPT2 for AAD. Transcriptome data demonstrated that a total of 18 genes were significantly up-regulated and 28 genes were significantly down-regulated among AAD tissues (foldchange>3.0, p < 0.01). By bioinformatic analysis, we identified ANGPT2 as a candidate biomarker for blood-based detection of AAD. The qRT-PCR and protein expression demonstrated that ANGPT2 increased 2.4- and 4.2 folds, respectively in aortic tissue of AAD patients. Immunohistochemical staining demonstrated that ANGPT2 was markedly increased in intima of the aortic wall in AAD. Furthermore, ANGPT2 was significantly elevated in AAD patients as compared with controls (median 1625 vs. 383 pg/ml, p < 1E-6). ROC curve analysis showed that ANGPT2 was highly predictive of a diagnosis of type A AAD (area under curve 0.93, p < 1E-6). Sensitivity and specificity were 81 and 90%, respectively at the cutoff value of 833 pg/ml. In conclusion, ANGPT2 could be a promising biomarker for diagnosis of AAD; however, more studies are still needed to verify its specificity in diagnosing of AAD.
No takes yet. Share an insight, caveat, or question.
Huang et al. (2021) conducted a case-control in Acute Aortic Dissection (n=159). Plasma Angiopoietin 2 (ANGPT2) level > 833 pg/ml vs. Plasma ANGPT2 level ≤ 833 pg/ml was evaluated on Diagnosis of Stanford type A acute aortic dissection (RR 47.297, 95% CI 16.497-135.601, p=<0.001). Plasma ANGPT2 levels > 833 pg/ml were independently associated with Stanford type A acute aortic dissection (RR 47.297) and showed high diagnostic accuracy with an AUC of 0.93.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: